Stocks · Health care · Pharmaceutical Preparations

Stoke Therapeutics, Inc.

STOK Clue Score65

United States Fiscal year ends December CIK 0001623526 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

By person

17 insiders · 267 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Skorpios Trust entity

10% owner

—

$122.58M (4)

−$122.58M

3,906,181

6.05%

$105.43M

−73.0%

ATP Life Science Ventures, L.P. entity

10% owner

$39.63M (2)

—

+$39.63M

0

0.0000%

$0.00

—

Seth Loring Harrison

Director

$39.63M (2)

—

+$39.63M

33,948,426

52.61%

$916.31M

+102.2%

Rtw Investments, LP entity

10% owner

$15.73M (6)

$471.63K (1)

+$15.25M

3,544,248

5.49%

$95.66M

—

Huw M. Nash

Chief Business Officer

—

$12.24M (48) scheduled

−$12.24M

0

0.0000%

$0.00

−100.0%

Edward M. MD Kaye

Director

—

$8.45M (31) scheduled

−$8.45M

124,557

0.1930%

$3.36M

—

Barry Ticho

Chief Medical Officer

—

$7.10M (78) scheduled

−$7.10M

11,864

0.0184%

$320.22K

+377.4%

Stephen J Tulipano

Former CFO

—

$4.52M (12) scheduled

−$4.52M

20,746

0.0322%

$559.96K

+3,346%

Adrian R. Krainer

Director

—

$3.90M (5) scheduled

−$3.90M

283,302

0.4390%

$7.65M

−30.0%

Jonathan Allan

General Counsel & Corp Sec

—

$2.84M (38) scheduled

−$2.84M

20,598

0.0319%

$555.97K

+108.3%

Gene Liau

EVP Research & Preclinical Dev

—

$2.60M (11) scheduled

−$2.60M

21,351

0.0331%

$576.29K

—

Arthur Tzianabos

Director

—

$1.70M (6) scheduled

−$1.70M

31,339

0.0486%

$845.88K

—

Arthur A Levin

Director

—

$782.11K (3) scheduled

−$782.11K

22,216

0.0344%

$599.64K

+23.6%

Thomas Leggett

Chief Financial Officer

—

$147.14K (5)

−$147.14K

10,172

0.0158%

$274.56K

—

Jason Hoitt

Chief Patient Officer

—

$119.31K (5)

−$119.31K

10,276

0.0159%

$277.36K

+157.7%

Robin A. Walker

Chief Legal Officer, CCO & Sec

—

$21.17K (1)

−$21.17K

0

0.0000%

$0.00

−100.0%

Redmile Group, LLC entity

10% owner

—

—

—

671,808

1.04%

$18.13M

—